The Rizatriptan Benzoate Tablet, cataloged under National Stock Number 6505-01-722-2116, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Macleods Pharma Usa, Inc.. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-722-2116 |
| Primary Part Number | NDC33342-0094-41 |
| Item Name | Rizatriptan Benzoate Tablet |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Macleods Pharma Usa, Inc. |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC33342-0094-41 PRIMARY | Macleods Pharma Usa, Inc. (USA) |
| 10190704 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| NDC33342-0094-41 | Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office (USA) |
| Reference | Meaning |
|---|---|
| RIZATRIPTAN | 5/1 Secondary reference Macleods Pharma Usa, Inc. |
| 1672379 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM249722 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-722-2116 is a Rizatriptan Benzoate Tablet, manufactured by Macleods Pharma Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-722-2116 has 3 manufacturer part numbers on file: NDC33342-0094-41 (Macleods Pharma Usa, Inc.), 10190704 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office), NDC33342-0094-41 (Amerisourcebergen Drug Corp Dba Amerisourcebergen Drug Corp Div Corporate Office).
Key specifications for NDC33342-0094-41: Special Features: RIZATRIPTAN 10 MG DISINTEGRATING TABLET UNIT DOSE. RIZATRIPTAN BENZOATE TABLETS ARE INDICATED FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS AND IN PEDIATRIC PATIENTS 6 TO 17 YEARS OLD.; Part Name Assigned by Controlling Agency: RIZATRIPTAN 10 MG DISINTEGRATING TABLET UNIT DOSE 18S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.